article thumbnail

Losing ground in COVID-19 vaccine race, CanSino turns to Russia

pharmaphorum

Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but the company says the project is back on track following regulatory approval to start trials in Russia. The post Losing ground in COVID-19 vaccine race, CanSino turns to Russia appeared first on.

article thumbnail

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Roots Analysis

It is worth noting that several companies have begun to develop mRNA-based cancer immunotherapies and vaccines for infectious diseases. mRNA Therapeutics and Vaccines Delivery Routes Efficient delivery of both therapeutic and vaccine candidates plays a key role in ensuring the effective expression and presentation of antigens.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111
article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

article thumbnail

Campaigners challenge NHS England’s latest plan to share patient data

pharmaphorum

The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively.

article thumbnail

Fentanyl vaccine shows potential as opioid use disorder treatment

Hospital Pharmacy Europe

A fentanyl vaccine induced significant antibody levels and reduced brain levels of the drug and could be of value in opiate use disorder. The principle is simple: a conjugate vaccine is designed to elicit an immune response to the abused opioid (e.g., Fentanyl vaccine effectiveness. Citation Haile CN et al.

article thumbnail

AstraZeneca plans new US R&D hub as revenues rocket

pharmaphorum

billion, three times the original estimate when the project was announced in 2013. The healthy sales increase was bolstered by the timing of orders for AZ’s COVID-19 vaccine Vaxzevria , which made $1.1 billion in the quarter but is expected to make less of a contribution in the remainder of the year.

Vaccines 111